Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A Non-genetic Mechanism Involving the Integrin ß4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer.
Association of TGF-ß1 Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case-Control Studies †.
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.
The Impact of Medicaid Expansion on Stage at Diagnosis of Melanoma Patients: A Retrospective Study.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.
Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol. 2018 10; 41(10):963-966.
View in:
PubMed
subject areas
Aged
Antineoplastic Combined Chemotherapy Protocols
Capecitabine
Celecoxib
Female
Follow-Up Studies
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Survival Rate
Thymus Neoplasms
authors with profiles
Ravi Salgia